Original Article

You have full text access to this OnlineOpen article

Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer

  1. Zhiqiang Meng MD, PhD1,
  2. Peiying Yang PhD2,
  3. Yehua Shen MD1,
  4. Wenying Bei RN1,
  5. Ying Zhang RN1,
  6. Yongqian Ge MD1,
  7. Robert A. Newman PhD3,†,
  8. Lorenzo Cohen PhD2,4,*,
  9. Luming Liu MD, PhD1,§,*,
  10. Bob Thornton MPH2,‡,
  11. David Z. Chang PhD5,
  12. Zongxing Liao MD6,
  13. Razelle Kurzrock MD7

Article first published online: 21 AUG 2009

DOI: 10.1002/cncr.24602

Issue

Cancer

Cancer

Volume 115, Issue 22, pages 5309–5318, 15 November 2009

Additional Information

How to Cite

Meng, Z., Yang, P., Shen, Y., Bei, W., Zhang, Y., Ge, Y., Newman, R. A., Cohen, L., Liu, L., Thornton, B., Chang, D. Z., Liao, Z. and Kurzrock, R. (2009), Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer, 115: 5309–5318. doi: 10.1002/cncr.24602

Author Information

  1. 1

    International Center of Integrative Oncology, Fudan University Cancer Hospital, Shanghai, China

  2. 2

    The Integrative Medicine Program, Department of General Oncology, The University of Texas M. D. Anderson Cancer, Houston, Texas

  3. 3

    Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  4. 4

    Department of Behavioral Science, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  5. 5

    Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  6. 6

    Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  7. 7

    Department of Investigational Cancer Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  1. †

    New Chapter Inc, Brattleboro, Vermont

  2. ‡

    Merck & Co, Inc., Whitehouse Station, New Jersey

  1. §

    Fax: (011) 862164437657

*Department of Behavioral Science, Unit 145, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030

Publication History

  1. Issue published online: 3 NOV 2009
  2. Article first published online: 21 AUG 2009
  3. Manuscript Accepted: 23 FEB 2009
  4. Manuscript Revised: 20 FEB 2009
  5. Manuscript Received: 3 SEP 2008

Funded by

  • National Cancer Institute. Grant Numbers: CA108084, CA12153031

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (293K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Bing Yan, Xianze Meng, Bian Shi, Jun Shi, Zhifeng Qin, Pinkang Wei, A retroperitoneal NF1-independent malignant peripheral nerve sheath tumor with elevated serum CA125: case report and discussion, Journal of Neuro-Oncology, 2012,

    CrossRef

  2. 2
    Shuli Man, Wenyuan Gao, Changlong Wei, Changxiao Liu, Anticancer Drugs from Traditional Toxic Chinese Medicines, Phytotherapy Research, 2012, 26, 5
    Direct Link:
  3. 3
    Wen-Wen Huang, Jai-Sing Yang, Shu-Jen Pai, Ping-Ping Wu, Shu-Jen Chang, Fu-Shin Chueh, Ming-Jen Fan, Shang-Ming Chiou, Hsiu-Maan Kuo, Chin-Chung Yeh, Po-Yuan Chen, Minoru Tsuzuki, Jing-Gung Chung, Bufalin induces G0/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2012, 732, 1-2, 26

    CrossRef

  4. 4
    Noriyuki Takai, Naoko Kira, Terukazu Ishii, Toshie Yoshida, Masakazu Nishida, Yoshihiro Nishida, Kaei Nasu, Hisashi Narahara, Bufalin, a Traditional Oriental Medicine, Induces Apoptosis in Human Cancer Cells, Asian Pacific Journal of Cancer Prevention, 2012, 13, 1, 399

    CrossRef

  5. 5
    Rui-Fang Xie, Zhi-Cheng Li, Bo Gao, Zhi-Na Shi, Xin Zhou, Bufothionine, a possible effective component in cinobufocini injection for hepatocellular carcinoma, Journal of Ethnopharmacology, 2012, 141, 2, 692

    CrossRef

  6. 6
    Libin Jia, Cancer complementary and alternative medicine research at the US national cancer institute, Chinese Journal of Integrative Medicine, 2012, 18, 5, 325

    CrossRef

  7. 7
    Fanghua Qi, Anyuan Li, Yoshinori Inagaki, Huanli Xu, Dongliang Wang, Xiaoyan Cui, Li Zhang, Norihiro Kokudo, Guanhua Du, Wei Tang, Induction of apoptosis by cinobufacini preparation through mitochondria- and Fas-mediated caspase-dependent pathways in human hepatocellular carcinoma cells, Food and Chemical Toxicology, 2012, 50, 2, 295

    CrossRef

  8. 8
    Hua-Yu Leo Wang, George A O’Doherty, Modulators of Na/K-ATPase: a patent review, Expert Opinion on Therapeutic Patents, 2012, 1

    CrossRef

  9. 9
    Prameet Kaur, Vibha Ghariwala, Kun Song Yeo, Hui Zhing Tan, Jian Chye Sam Tan, Arunmozhiarasi Armugam, Peter N. Strong, Kandiah Jeyaseelan, Advances in Clinical Chemistry Volume 57, 2012,

    CrossRef

  10. 10
    Fanghua Qi, Anyuan Li, Yoshinori Inagaki, Norihiro Kokudo, Sumihito Tamura, Munehiro Nakata, Wei Tang, Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor, International Immunopharmacology, 2011, 11, 3, 342

    CrossRef

  11. 11
    Hongyue Ma, Junfeng Zhang, Jiejun Jiang, Jing Zhou, Huiqin Xu, Zhen Zhan, Qinan Wu, Jinao Duan, Bilirubin Attenuates Bufadienolide-Induced Ventricular Arrhythmias and Cardiac Dysfunction in Guinea-Pigs by Reducing Elevated Intracellular Na+ Levels, Cardiovascular Toxicology, 2011, 12, 1, 83

    CrossRef

  12. 12
    Xing Zhang, Min Ye, Yin-Hui Dong, Hong-Bo Hu, Si-Jia Tao, Guang-Tong Chen, Jun Yin, De-An Guo, Biotransformation of arenobufagin and cinobufotalin byAlternaria alternata, Biocatalysis and Biotransformation, 2011, 29, 2-3, 96

    CrossRef

  13. 13
    Yinhui Dong, Shutao Yin, Jinghua Li, Cheng Jiang, Min Ye, Hongbo Hu, Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3/Mcl-1 pathway, Apoptosis, 2011, 16, 4, 394

    CrossRef

  14. You have free access to this content14
    Fanghua Qi, Yoshinori Inagaki, Bo Gao, Xiaoyan Cui, Huanli Xu, Norihiro Kokudo, Anyuan Li, Wei Tang, Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas- and mitochondria-mediated pathways, Cancer Science, 2011, 102, 5
    Direct Link:
  15. 15
    Chuan-Ming Xie, Wood Yee Chan, Sidney Yu, Jun Zhao, Christopher H.K. Cheng, Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation, Free Radical Biology and Medicine, 2011, 51, 7, 1365

    CrossRef

  16. 16
    Dong-Liang Wang, Fang-Hua Qi, Wei Tang, Feng-Shan Wang, Chemical Constituents and Bioactivities of the Skin of Bufo bufo gargarizansCantor, Chemistry & Biodiversity, 2011, 8, 4
    Direct Link:
  17. 17
    Glenn F King, Venoms as a platform for human drugs: translating toxins into therapeutics, Expert Opinion on Biological Therapy, 2011, 11, 11, 1469

    CrossRef

  18. 18
    Xiaoyan Cui, Yoshinori Inagaki, Huanli Xu, Dongliang Wang, Fanghua Qi, Norihiro Kokudo, Dingzhi Fang, Wei Tang, Anti-hepatitis B Virus Activities of Cinobufacini and Its Active Components Bufalin and Cinobufagin in HepG2.2.15 Cells, Biological & Pharmaceutical Bulletin, 2010, 33, 10, 1728

    CrossRef

  19. 19
    Junqiang Ye, Shuibing Chen, Tom Maniatis, Cardiac glycosides are potent inhibitors of interferon-β gene expression, Nature Chemical Biology, 2010, 7, 1, 25

    CrossRef

  20. 20
    Tracey Baas, Cardiac glycosides: a leap to lupus?, Science-Business eXchange, 2010, 3, 46

    CrossRef

  21. 21
    Huimin Gao, Martin Zehl, Alexander Leitner, Xiyan Wu, Zhimin Wang, Brigitte Kopp, Comparison of toad venoms from different Bufo species by HPLC and LC-DAD-MS/MS, Journal of Ethnopharmacology, 2010, 131, 2, 368

    CrossRef

  22. 22
    Yongtao Jiang, Ying Zhang, Jinling Luan, Huiying Duan, Feng Zhang, Kazumi Yagasaki, Guoying Zhang, Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action, Cytotechnology, 2010, 62, 6, 573

    CrossRef

View Full Article (HTML) Get PDF (293K)